Shields Raymond C
Cardiovascular Division, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA.
Perspect Vasc Surg Endovasc Ther. 2010 Mar;22(1):18-27. doi: 10.1177/1531003510380929.
Stroke is a leading cause of morbidity and mortality in the developed world. Although the rates of stroke have decreased in North America, there are significant areas of risk stratification and management that can be improved. Hypertension is the most significant and perhaps most modifiable risk factor for stroke. Carotid atherosclerotic disease is associated with 15% of ischemic strokes. Although carotid endarterectomy (CEA) remains a recommendation for significant symptomatic carotid stenosis, controversy continues in the management of asymptomatic and recurrent carotid stenosis. Medical management options and effectiveness has significantly improved since the early CEA trials were published. Optimal medical management now must incorporate aggressive risk factor reduction measures, particularly with antihyperlipidemic therapy. Improved understanding of the natural history of carotid atherosclerosis is necessary to improve the application of management strategies.
中风是发达国家发病和死亡的主要原因。尽管北美中风发病率有所下降,但在风险分层和管理的重要领域仍有改进空间。高血压是中风最重要且或许最可改变的风险因素。颈动脉粥样硬化疾病与15%的缺血性中风相关。虽然颈动脉内膜切除术(CEA)仍是有显著症状性颈动脉狭窄的推荐治疗方法,但在无症状和复发性颈动脉狭窄的管理方面仍存在争议。自早期CEA试验发表以来,药物治疗选择和效果有了显著改善。现在最佳的药物治疗必须纳入积极的风险因素降低措施,尤其是抗高脂血症治疗。更好地了解颈动脉粥样硬化的自然病程对于改进管理策略的应用很有必要。